Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Kim

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 23, 2023
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)Kyoo Hyun Kim, Minkyu Jung, Hyo Jin Lee, et al.
ACS Applied Materials & Interfaces|April 11, 2024
Utilizing a High-Performance Piezoelectric Nanocomposite as a Self-Activating Component in Piezotronic Artificial MechanoreceptorsTrung Dieu Do, Tran Quang Trung, Anh Le Mong, et al.
Translational Cancer Research|February 4, 2022
Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16)Seonggyu Byeon, Myoung Joo Kang, Yoon Ji Choi, et al.
Cancer Research and Treatment|May 4, 2021
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non-Small Cell Lung CancerChaelin Lee, Miso Kim, Dong-Wan Kim, et al.
Cancer Research and Treatment|February 13, 2014
Adenoid cystic carcinoma of the breast: a case series of six patients and literature reviewMiso Kim, Dae-Won Lee, Jin Im, et al.
Journal for Immunotherapy of Cancer|August 25, 2020
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell linesJi-Eun Park, Seong-Eun Kim, Bhumsuk Keam, et al.
Scientific Reports|July 31, 2019
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levelsChan Joo Lee, Mun Su Park, Miso Kim, et al.
World Journal of Surgical Oncology|February 14, 2014
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancerMiso Kim, Hyun Chang, Hee Chul Yang, et al.
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Iscience|February 3, 2025
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in <i>EGFR</i>-mutant non-small cell lung cancerSoomin Kim, Jaemoon Koh, Tae Min Kim, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|September 23, 2023
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)Kyoo Hyun Kim, Minkyu Jung, Hyo Jin Lee, et al.
ACS Applied Materials & Interfaces|April 11, 2024
Utilizing a High-Performance Piezoelectric Nanocomposite as a Self-Activating Component in Piezotronic Artificial MechanoreceptorsTrung Dieu Do, Tran Quang Trung, Anh Le Mong, et al.
Translational Cancer Research|February 4, 2022
Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16)Seonggyu Byeon, Myoung Joo Kang, Yoon Ji Choi, et al.
Cancer Research and Treatment|May 4, 2021
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non-Small Cell Lung CancerChaelin Lee, Miso Kim, Dong-Wan Kim, et al.
Cancer Research and Treatment|February 13, 2014
Adenoid cystic carcinoma of the breast: a case series of six patients and literature reviewMiso Kim, Dae-Won Lee, Jin Im, et al.
Journal for Immunotherapy of Cancer|August 25, 2020
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell linesJi-Eun Park, Seong-Eun Kim, Bhumsuk Keam, et al.
Scientific Reports|July 31, 2019
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levelsChan Joo Lee, Mun Su Park, Miso Kim, et al.
World Journal of Surgical Oncology|February 14, 2014
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancerMiso Kim, Hyun Chang, Hee Chul Yang, et al.
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Iscience|February 3, 2025
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in <i>EGFR</i>-mutant non-small cell lung cancerSoomin Kim, Jaemoon Koh, Tae Min Kim, et al.
Pageof 19